NCT05167708

Brief Summary

the study aimed to evaluate the effect of different types of Micro-osteoperforation on the rate of distal movement of maxillary first molars as a primary out come. Besides, it was aimed to study secondary effect on the first molars by evaluating root resorption, bone density, and level of the pain during performing the procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 30, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 22, 2021

Completed
Last Updated

December 22, 2021

Status Verified

December 1, 2021

Enrollment Period

2.5 years

First QC Date

November 30, 2021

Last Update Submit

December 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • rate of maxillary first molar distal movement

    evaluation of the whole rate of distal movement of the first molar

    through study completion, an average 1 year

Secondary Outcomes (3)

  • decrease in length of maxillary first molars in mm.

    through study completion, an average 1 year

  • bone density

    through study completion, an average 1 year

  • pain perception questionnaire

    through study completion, an average 1 year

Study Arms (3)

control

NO INTERVENTION

the group underwent distalization, with no Micro-osteoperforation

Single MOP

EXPERIMENTAL

the group underwent one time Micro-osteoperforation procedure

Procedure: Micro-osteoperforation

repeated MOP

EXPERIMENTAL

the group underwent monthly Micro-osteoperforation procedure

Procedure: Micro-osteoperforation

Interventions

flapless small punctures in the bone at direction of tooth movement to accelerate the movement.

Single MOPrepeated MOP

Eligibility Criteria

Age16 Years - 20 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailssexual hormones could affect the study outcomes. aiming to minimize the factors that might cause bias of the results.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Space deficiency in the upper arch \> 5 mm, and \< 8 mm.
  • Non-extraction lower arch.
  • Full upper dentition up to the second molars.
  • Third molar present in both sides, not yet erupted.

You may not qualify if:

  • Systemic disease or syndrome.
  • Evidence of root resorption.
  • Poor oral hygiene.
  • Previous orthodontic treatment
  • Evidence of bone loss.
  • Active periodontal disease.
  • Pregnant females.
  • Presence of oral habits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

MeSH Terms

Conditions

Dental Deposits

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Officials

  • yasser lotfy, professor

    Mansoura University

    STUDY CHAIR
  • marwaa shamaa, ph.D

    Mansoura University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
single blinded, the assessor of the out comes did not participate in the study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-center, prospective, single blinded, with 3 parallel arms, randomized clinical trial that had a 1:1:1 allocation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

November 30, 2021

First Posted

December 22, 2021

Study Start

April 1, 2019

Primary Completion

September 30, 2021

Study Completion

November 1, 2021

Last Updated

December 22, 2021

Record last verified: 2021-12

Locations